FOURTEAU PATRICK
Insider CIK 1235637 · INSY Director · RPRX President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RPRX REPROS THERAPEUTICS INC. | D To issuer deriv | 2018-01-31 | 2018-01-31 | 5,000 | — | $0 | 0 | SEC↗ |
| RPRX REPROS THERAPEUTICS INC. | D To issuer | 2018-01-31 | 2018-01-31 | 27,779 | $0.67 | $18.6K | 0 | SEC↗ |
| RPRX REPROS THERAPEUTICS INC. | U Tender | 2018-01-29 | 2018-01-31 | 12,221 | $0.67 | $8.2K | 27,779 | SEC↗ |
| RPRX REPROS THERAPEUTICS INC. | A Award deriv | 2017-09-15 | 2017-09-18 | 5,000 | — | $0 | 5,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | M Exercise deriv | 2017-08-04 | 2017-08-04 | 10,000 | — | $0 | 63,770 | SEC↗ |
| INSY Insys Therapeutics, Inc. | M Exercise | 2017-08-04 | 2017-08-04 | 10,000 | $1.62 | $16.2K | 69,682 | SEC↗ |
| INSY Insys Therapeutics, Inc. | M Exercise deriv | 2017-05-26 | 2017-05-26 | 10,000 | — | $0 | 50,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | M Exercise | 2017-05-26 | 2017-05-26 | 10,000 | $3.63 | $36.3K | 59,682 | SEC↗ |
| INSY Insys Therapeutics, Inc. | A Award deriv | 2017-02-21 | 2017-02-23 | 16,000 | — | $0 | 16,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | A Award deriv | 2017-02-21 | 2017-02-23 | 4,000 | — | $0 | 4,000 | SEC↗ |
| RPRX REPROS THERAPEUTICS INC. | A Award | 2017-02-13 | 2017-02-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | S Sale | 2016-08-11 | 2016-08-12 | 15,000 | $18.46 | $276.9K | 49,682 | SEC↗ |
| RPRX REPROS THERAPEUTICS INC. | A Award deriv | 2016-06-30 | 2016-07-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RPRX REPROS THERAPEUTICS INC. | A Award deriv | 2016-05-12 | 2016-05-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | A Award deriv | 2016-05-02 | 2016-05-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | S Sale | 2016-03-04 | 2016-03-04 | 15,000 | $18.22 | $273.3K | 64,682 | SEC↗ |
| INSY Insys Therapeutics, Inc. | S Sale | 2015-11-12 | 2015-11-13 | 30,000 | $26.48 | $794.4K | 79,682 | SEC↗ |
| INSY Insys Therapeutics, Inc. | S Sale | 2015-05-27 | 2015-05-27 | 1,311 | $60.14 | $78.8K | 54,841 | SEC↗ |
| INSY Insys Therapeutics, Inc. | S Sale | 2015-05-26 | 2015-05-27 | 4,784 | $60.00 | $287.0K | 56,152 | SEC↗ |
| INSY Insys Therapeutics, Inc. | S Sale | 2015-05-20 | 2015-05-20 | 6,095 | $60.00 | $365.7K | 60,936 | SEC↗ |
| INSY Insys Therapeutics, Inc. | S Sale | 2015-05-19 | 2015-05-20 | 2,969 | $60.00 | $178.1K | 67,031 | SEC↗ |
| INSY Insys Therapeutics, Inc. | A Award deriv | 2015-05-05 | 2015-05-07 | 9,000 | — | $0 | 9,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | S Sale | 2015-03-11 | 2015-03-12 | 10,000 | $59.94 | $599.4K | 70,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | S Sale | 2014-11-19 | 2014-11-20 | 25,000 | $39.11 | $977.8K | 80,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | A Award deriv | 2014-08-07 | 2014-08-11 | 9,000 | — | $0 | 9,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | P Buy | 2014-05-15 | 2014-05-15 | 4,500 | $22.95 | $103.3K | 102,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | P Buy | 2014-05-15 | 2014-05-15 | 3,000 | $22.50 | $67.5K | 105,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | P Buy | 2013-08-14 | 2013-08-15 | 5,000 | $23.77 | $118.8K | 65,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | A Award deriv | 2013-05-14 | 2013-05-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | P Buy | 2013-05-14 | 2013-05-14 | 5,000 | $10.90 | $54.5K | 60,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | P Buy | 2013-05-13 | 2013-05-13 | 2,000 | $11.10 | $22.2K | 55,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | P Buy | 2013-05-09 | 2013-05-13 | 2,800 | $10.75 | $30.1K | 53,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | P Buy | 2013-05-08 | 2013-05-13 | 200 | $10.40 | $2.1K | 50,200 | SEC↗ |
| INSY Insys Therapeutics, Inc. | P Buy | 2013-05-07 | 2013-05-08 | 37,500 | $8.00 | $300.0K | 37,500 | SEC↗ |
| INSY Insys Therapeutics, Inc. | P Buy | 2013-05-07 | 2013-05-08 | 12,500 | $9.45 | $118.1K | 50,000 | SEC↗ |